ArticleCureus2023

Do Tofacitinib Generics Exhibit Conventional Synthetic Disease-Modifying Anti-rheumatic Drug and Non-steroidal Anti-inflammatory Drug-Sparing Ability in the Management of Axial Spondyloarthritis?

Arvind Ganapati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.